| Literature DB >> 35855787 |
Siranjeevi Ravichandran1, Rajesh Jegathaprathaban1, Jeyalakshmi Radhakrishnan2, R Usha3, V Vijayan4, Aklilu Teklemariam5.
Abstract
The in vitro antibacterial, anticancer, and antioxidant activities of a few plant extracts were widely known for decades, and they were used for application in the conventional way. Specifically, electrospun nanofibrous mats have recently exhibited great antibacterial, anticancer, and antioxidant activities. The herbal extracts infused into these formations are expected to have a more efficient and integrated effect on in vitro biological applications. The purpose of this study is to develop polycaprolactone- (PCL-) based nanofiber mats that are infused with a traditional plant extract using Clerodendrum phlomidis leaves to improve the synthesized nanofibers' antibacterial, anticancer, and antioxidant efficacy. This study examined the morphology, thermal properties, mechanical properties, structure, and in vitro drug release studies of electrospun nanofibers. Antibacterial, anticancer, and antioxidant activities of the electrospun nanofibrous mats were also studied. The HRTEM and FESEM pictures of PCL and PCL-CPM nanofibers provide that smooth, defect-free, and homogeneous nanofibers were found to be 602.08 ± 75 nm and 414.15 ± 82 nm for PCL and PCL-CPM nanofibers, respectively. The presence of Clerodendrum phlomidis extract in the electrospun nanofibers was approved by UV-visible and FTIR spectroscopy. The incorporation of Clerodendrum phlomidis extract to nanofiber mats resulted in substantial antibacterial activity against bacterial cells. PCL-CPM mats exposed to oral cancer (HSC-3) and renal cell carcinoma (ACHN) cell lines displayed promising anticancer activity with less than 50% survival rate after 24 h of incubation. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay performed on PCL-CPM nanofibers revealed the antioxidant scavenging activity with maximum inhibition of 34% suggesting the role of the secondary metabolites release from scaffold. As a result, the findings of this study revealed that Clerodendrum phlomidis extract encapsulating PCL electrospun nanofibers has a high potential for usage as a biobased antibacterial, anticancer, and antioxidant agent.Entities:
Year: 2022 PMID: 35855787 PMCID: PMC9288331 DOI: 10.1155/2022/2335443
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 4.724
Figure 1Schematic diagram display electrospinning setup used to prepare CPM extract-infused PCL nanofibers (PCL-CPM nanofibers).
Figure 2SEM images of electrospun nanofibers: (a)PCL and (b) PCL-CPM nanofibers. The fiber distribution is represented in the extreme right column.
Figure 3TEM image of PCL and PCL-CPM nanofibers.
Figure 4(a) FTIR and (b) UV-visible spectrum.
Figure 5(a) TGA thermograms and (b) DSC thermograms.
Figure 6Water contact angle for PCL (a0s–bafter60s) and PCL-CPM (c0s—dafter60s) (Figure 6 is reproduced from Kim et al. [36]).
Water contact angle of PCL and PCL-CPM nanofibers.
| Sample | 0 Second | 60 Second |
|---|---|---|
| PCL | 136.90 ± 0.46 | 135 ± 0.36 |
| PCL-CPM | 93.07 ± 0.52 | 45.81 ± 0.42 |
Figure 7(a) Mechanical properties. (b) Cumulative release profile. (c) Quantitative analysis of CPM extract and D. GC-MS analysis of CPM extract (Figure 7 is reproduced from Kim et al. [36]).
Morphological characteristics and mechanical properties of PCL and PCL-CPM nanofibers.
| Sample | Ave. fiber diameter (mm) | Tensile strength (MPa) | Elongation at break (%) | Young's modulus (MPa) |
|---|---|---|---|---|
| PCL | 617.91 ± 165 | 2.2066 ± 0.543 | 131.153 ± 0.023 | 0.532 ± 0.519 |
| PCL-CPM | 426.77 ± 142 | 1.1626 ± 0.606 | 43.576 ± 0.625 | 27.24 ± 0.362 |
Preliminary phytochemical screening of methanol extract of Clerodendrum phlomidis.
| S. No | Phytochemicals | Methanol Extract |
|---|---|---|
| 1 | Alkaloids | + |
| 2 | Amino acids | − |
| 3 | Anthocyanin | − |
| 4 | Carbohydrates | + |
| 5 | Coumarin | − |
| 6 | Cardio Glycosides | − |
| 7 | Diterpene | + |
| 8 | Emodins | − |
| 9 | Flavonoids | + |
| 10 | Fatty acid | − |
| 11 | Leucoanthocyanin | − |
| 12 | Glycosides | + |
| 13 | Phlobatannin | − |
| 14 | Proteins | − |
| 15 | Phenols | + |
| 16 | Quinones | − |
| 17 | Saponin | + |
| 18 | Steroids | + |
| 19 | Tannins | + |
| 20 | Terpenoids | + |
GC-MS spectral analysis of methanol extract of Clerodendrum Phlomidis.
| S. No | RT (min) | Name of the compound | Peak area (%) | Molecular weight | Molecular formula |
|---|---|---|---|---|---|
| 1 | 3.05 | Ethanedial dihydrazone | 0.2 | 86 | C2H6N4 |
| 2 | 3.15 | 1-Chloro-2-isocyanotoethane | 0.33 | 105 | C3H4ClNO2 |
| 3 | 3.70 | 2-Butene,1-methoxy-,(E)- | 0.43 | 86 | C5H10O |
| 4 | 5.30 | 2,4-Pentadiensaecre,1-cyclopenten-3-on-1-yl ester | 0.16 | 178 | C10H10O3 |
| 5 | 5.53 | 1,2,3,-Propanetriol | 5.95 | 92 | C3H8O2 |
| 6 | 5.68 | Phenol | 0.56 | 94 | C6H6O |
| 7 | 5.78 | Propane,1,1-dihydroxy-2-methyl-1,1-Diethoxy-2-methylpropane | 0.38 | 146 | C8H18O2 |
| 8 | 7.05 | 1,5-Heptadien-4-one,3,36-trimethyl- | 0.14 | 152 | C10H16O |
| 9 | 7.30 | Oxirane, phenyl- | 0.35 | 120 | C8H8O |
| 10 | 7.77 | 2-Chloro-1-ethyl-1-methyl cyclopropane | 0.14 | 118 | C6H11Cl |
| 11 | 7.95 | Thymine | 0.21 | 126 | C5H6N2O2 |
| 12 | 8.97 | Pentafluoropropionic acid, pentyl ester | 0.16 | 234 | C8H11F5O2 |
| 13 | 9.80 | 1,5-Anhydro-6-deoxyhexo-2,3-diulose | 0.5 | 144 | C6H8O4 |
| 14 | 10.73 | Furan,2,3-dihydro-5-methyl- | 0.13 | 84 | C5H8O |
| 15 | 10.80 | 1-Chloro-2-isocyanatoethane | 0.23 | 105 | C3H4ClNO |
| 16 | 10.96 | 3,4-Anhydro-d-galactosan | 0.19 | 144 | C6H8O4 |
| 17 | 11.98 | 3-Pyridinecarboxylic acid | 0.81 | 123 | C6H5NO2 |
| 18 | 12.44 | Benzeneacetic acid | 0.26 | 136 | C8H8O2 |
| 19 | 14.30 | 2-Methoxy-3-methyl-butyric acid, methyl ester | 1.45 | 146 | C7H14O3 |
| 20 | 14.65 | Hexane,3-methoxy-3-methyl- | 0.44 | 130 | C8H8O |
| 21 | 16.62 | Cyclohexane, (2-methoxyethyl)- | 0.37 | 142 | C9H18O |
| 22 | 16.76 | Oxirane,2,2ؙ-(1,4-butanediyl)bis- | 0.2 | 142 | C8H14O2 |
| 23 | 17.34 | Cyclohexanol,2,6-dimethyl- | 0.21 | 128 | C8H16O |
| 24 | 19.25 | 2,6-Di-tert-butyl-4-methylphenol | 0.82 | 220 | C15H24O |
| 25 | 19.96 | 1 (2H)-isoquinolinone | 0.42 | 145 | C9H7NO |
| 26 | 21.98 | Methyl beta-d-galactopyranoside | 0.52 | 194 | C7H14O6 |
| 27 | 21.98 | L-(+)-Lactic acid, trimethylsilyl ester | 0.14 | 162 | C6H14O3Si |
| 28 | 24.53 | p-Toluic acid,2-octyl ester | 0.24 | 248 | C16H24O2 |
| 29 | 24.79 | 2-Propenoic acid,3 (3-hydroxyphenyl)- methyl ester | 0.14 | 178 | C5H10O3 |
| 30 | 25.05 | Decanoic acid | 0.31 | 172 | C10H20O2 |
| 31 | 25.24 | 4,5-Heptadien-2-ol,3,3,6-Trimethyl- | 0.15 | 154 | C10H18O |
| 32 | 25.65 | Methyl benzoate | 0.35 | 136 | C8H8O2 |
| 33 | 26.45 | p-Hydroxycinnamic acid, ethyl ester | 0.29 | 192 | C11H12O3 |
| 34 | 26.76 | Z-4-Dodecenol | 0.14 | 184 | C12H24O |
| 35 | 28.54 | Hexadecanoic acid, methyl ester | 0.31 | 270 | C17H34O2 |
| 36 | 29.20 | n-Hexadecanoic acid | 4.18 | 256 | C18H32O2 |
| 37 | 29.72 | Ethyl,9-Hexadecenote | 1.17 | 282 | C18H34O2 |
| 38 | 29.87 | Hexadecanoic acid, ethyl ester | 14.43 | 284 | C18H36O2 |
| 39 | 32.05 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | 31.58 | 296 | C20H40O |
| 40 | 32.39 | 9,12-Octadecadien-1-ol | 0.53 | 266 | C18H34O |
| 41 | 32.49 | 9,12,15-Octadecatrienoic acid | 1.09 | 278 | C18H30O2 |
| 42 | 33.56 | Ethyl (9Z,12Z)-9,12-octadecadienoate | 3.19 | 308 | C20H36O2 |
| 43 | 33.74 | Octadecanoate, ethyl ester | 1.04 | 312 | C20H40O2 |
| 44 | 36.54 | 3-Hexenoic acid,5-hydroxy-2-methyl ester [R | 0.16 | 158 | C8H14O3 |
| 45 | 37.83 | Hexadecanoic acid,2-hydroxy-1-(hydroxy methyl) ethyl ester | 0.14 | 330 | C19H38O4 |
Figure 8Antibacterial activity of extract (CPM), PCL and PCL-CPM nanofibrous mats: (a) E. coli, (b) S. aureus, (c) S. typhi, and (d) P. aeruginosa.
Figure 9(a) E. coli, (b) S. aureus, (c) S. typhi, and (d) P. aeruginosa. Zone of inhibition with crude extract (C. phlomidis), PCL, and PCL-CPM nanofibrous mats.
Figure 10A diagrammatic representation of the mechanisms of antibacterial activity of the nanofibers.
Figure 11Cytotoxicity of the blank PCL and PCL-CPM nanofibers to the ACHN (renal cell carcinoma) cells. (a) Blank control, (b) 0% (blank PCL), and (c) PCL-CPM nanofiber.
Figure 12Cytotoxicity of the blank PCL and PCL-CPM nanofibers to the HSC-3 (oral cancer) cells: (a) blank control, (b) 0% (blank PCL), and (c) PCL-CPM nanofiber.
Figure 13A diagrammatic representation of the mechanisms of anticancer activity of nanofibers.
Figure 14(a). Antioxidant activity of CPM extract at various concentration levels with time. (A) 100, (B), 200, (C) 300, (D) 400, and (E) 500). (b). Antioxidant activity of PCL-CPM electrospun nanofibers with time.